Burnouf Pierre-Alain

2022

Engineering a High-Affinity Anti-Methoxy Poly(ethylene glycol) (mPEG) Antibody for Sensitive Immunosensing of mPEGylated Therapeutics and mPEG Molecules

Hsiao, C. Y., Meng, J. L., Hong, J. Z., Ly, X. H., Lin, M. H., Chang, C. Y., Nguyen, M. T. T., Cheng, T. L., Lin, W. W., Burnouf, P. A., Al-Qaisi, T. S., Liu, E. S. & Su, Y. C., 2022 11月 16, 於: Bioconjugate Chemistry. 33, 11, p. 2180-2188 9 p.

研究成果: Article › 同行評審

2021

Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity

Lin, H. Y., Chen, C. Y., Lin, T. C., Yeh, L. F., Hsieh, W. C., Gao, S., Burnouf, P. A., Chen, B. M., Hsieh, T. J., Dashnyam, P., Kuo, Y. H., Tu, Z., Roffler, S. R. & Lin, C. H., 2021 12月, 於: Communications Biology. 4, 1, 280.

研究成果: Article › 同行評審

開啟存取

24 引文斯高帕斯（Scopus）

2018

Reversible glycosidic switch for secure delivery of molecular nanocargos

Burnouf, P. A., Leu, Y. L., Su, Y. C., Wu, K., Lin, W. C. & Roffler, S. R., 2018 12月 1, 於: Nature communications. 9, 1, 1843.

研究成果: Article › 同行評審

開啟存取

15 引文斯高帕斯（Scopus）

2017

Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy

Su, Y. C., Burnouf, P. A., Chuang, K. H., Chen, B. M., Cheng, T. L. & Roffler, S. R., 2017 6月 8, 於: Nature communications. 8, 15507.

研究成果: Article › 同行評審

開啟存取

62 引文斯高帕斯（Scopus）

2016

Engineering chimeric receptors to investigate the size- and rigidity-dependent interaction of pegylated nanoparticles with cells

Huang, W. C., Burnouf, P. A., Su, Y. C., Chen, B. M., Chuang, K., Lee, C. W., Wei, P. K., Cheng, T. L. & Roffler, S. R., 2016 1月 26, 於: ACS nano. 10, 1, p. 648-662 15 p.

研究成果: Article › 同行評審

33 引文斯高帕斯（Scopus）

Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals

Chen, B. M., Su, Y. C., Chang, C. J., Burnouf, P. A., Chuang, K. H., Chen, C. H., Cheng, T. L., Chen, Y. T., Wu, J. Y. & Roffler, S. R., 2016 11月 1, 於: Analytical Chemistry. 88, 21, p. 10661-10666 6 p.

研究成果: Article › 同行評審

157 引文斯高帕斯（Scopus）

Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation

Prijovich, Z. M., Burnouf, P. A., Chou, H. C., Huang, P. T., Chen, K. C., Cheng, T. L., Leu, Y. L. & Roffler, S. R., 2016 4月 4, 於: Molecular Pharmaceutics. 13, 4, p. 1242-1250 9 p.

研究成果: Article › 同行評審

25 引文斯高帕斯（Scopus）

2015

Selective delivery of PEGylated compounds to tumor cells by anti-PEG hybrid antibodies

Tung, H. Y., Su, Y. C., Chen, B. M., Burnouf, P. A., Huang, W. C., Chuang, K. H., Yan, Y. T., Cheng, T. L. & Roffler, S. R., 2015 6月 1, 於: Molecular cancer therapeutics. 14, 6, p. 1317-1326 10 p.

研究成果: Article › 同行評審

開啟存取

33 引文斯高帕斯（Scopus）

2014

Versatile online SPE-HPLC method for the analysis of Irinotecan and its clinically relevant metabolites in biomaterials

Prijovich, Z. M., Burnouf, P. A. & Roffler, S. R., 2014 2月, 於: Journal of Separation Science. 37, 4, p. 360-367 8 p.

研究成果: Article › 同行評審

9 引文斯高帕斯（Scopus）

2010

A novel virally inactivated human platelet lysate preparation rich in TGF-β, EGF and IGF, and depleted of PDGF and VEGF

Burnouf, P. A., Juan, P. K., Su, C. Y., Kuo, Y. P., Chou, M. L., Su, C. H., Tseng, Y. H., Lin, C. T. & Burnouf, T., 2010 8月, 於: Biotechnology and Applied Biochemistry. 56, 4, p. 151-160 10 p.

研究成果: Article › 同行評審

13 引文斯高帕斯（Scopus）

白 宸睿

研究成果

搜尋結果

白宸睿